195 related articles for article (PubMed ID: 12720149)
21. Prognostic role of angiogenesis in colorectal cancer.
Papamichael D
Anticancer Res; 2001; 21(6B):4349-53. PubMed ID: 11908690
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents.
Cibeira MT; Rozman M; Segarra M; Lozano E; Rosiñol L; Cid MC; Filella X; Bladé J
Cytokine; 2008 Mar; 41(3):244-53. PubMed ID: 18178097
[TBL] [Abstract][Full Text] [Related]
23. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma.
Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM
Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885
[TBL] [Abstract][Full Text] [Related]
24. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.
Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308
[TBL] [Abstract][Full Text] [Related]
25. [The role of angiogenesis in rheumatoid arthritis].
Pałgan K
Postepy Hig Med Dosw; 2000; 54(6):855-65. PubMed ID: 11227381
[TBL] [Abstract][Full Text] [Related]
26. Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells.
Uneda S; Matsuno F; Sonoki T; Tniguchi I; Kawano F; Hata H
Haematologica; 2003 Jan; 88(1):113-5. PubMed ID: 12551836
[No Abstract] [Full Text] [Related]
27. Molecular control of physiological skin angiogenesis.
Odorisio T; Failla CM; Zambruno G
Eur J Dermatol; 2002; 12(6):VII-X. PubMed ID: 12506892
[No Abstract] [Full Text] [Related]
28. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.
Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE
Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis in hematologic malignancies.
Moehler TM; Neben K; Ho AD; Goldschmidt H
Ann Hematol; 2001 Dec; 80(12):695-705. PubMed ID: 11797109
[TBL] [Abstract][Full Text] [Related]
30. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
31. Absence of clinical prognostic value of vascular endothelial growth factor and microvessel density in multiple myeloma.
Choi JH; Ahn MJ; Jang SJ; Park CK; Park YW; Oh HS; Lee YY; Choi IY; Kim IS
Int J Hematol; 2002 Dec; 76(5):460-4. PubMed ID: 12512841
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis in hematologic malignancies.
Mesters RM
Ann Hematol; 2002; 81 Suppl 2():S72-4. PubMed ID: 12611085
[No Abstract] [Full Text] [Related]
33. Antiangiogenic therapy in leukemia.
Thomas DA; Giles FJ; Cortes J; Albitar M; Kantarjian HM
Acta Haematol; 2001; 106(4):190-207. PubMed ID: 11815717
[TBL] [Abstract][Full Text] [Related]
34. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
35. [Clinical development of anti-angiogenic agents in 2002].
Bachelot T; Jouanneau E; Blay JY
Bull Cancer; 2003 Jan; 90(1):19-23. PubMed ID: 12609800
[TBL] [Abstract][Full Text] [Related]
36. Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression.
Kline M; Donovan K; Wellik L; Lust C; Jin W; Moon-Tasson L; Xiong Y; Witzig TE; Kumar S; Rajkumar SV; Lust JA
Leuk Res; 2007 May; 31(5):591-8. PubMed ID: 16879867
[TBL] [Abstract][Full Text] [Related]
37. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival.
Andersen NF; Standal T; Nielsen JL; Heickendorff L; Borset M; Sørensen FB; Abildgaard N
Br J Haematol; 2005 Jan; 128(2):210-7. PubMed ID: 15638855
[TBL] [Abstract][Full Text] [Related]
38. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed during the remodeling of free tendon grafts in sheep.
Petersen W; Unterhauser F; Pufe T; Zantop T; Südkamp NP; Weiler A
Arch Orthop Trauma Surg; 2003 May; 123(4):168-74. PubMed ID: 12734715
[TBL] [Abstract][Full Text] [Related]
39. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
40. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
